Cost-Effectiveness of the US Food and Drug Administration Added Sugar Labeling Policy for Improving Diet and Health

Circulation

Volumn 139, Issue 23, 2019, Pages 2613-2624

  Huang, Yue ^a   Kypridemos, Chris ^b   Liu, Junxiu ^a   Lee, Yujin ^a   Pearson Stuttard, Jonathan ^b,c   Collins, Brendan ^b,d   Bandosz, Piotr ^b   Capewell, Simon ^b   Whitsel, Laurie ^e   Wilde, Parke ^a   Mozaffarian, Dariush ^a   O'Flaherty, Martin ^b   Micha, Renata ^a  

^a TUFTS UNIVERSITY   (United States)

^b UNIVERSITY OF LIVERPOOL   (United Kingdom)

^c IMPERIAL COLLEGE LONDON   (United Kingdom)

^d MEDICAL UNIVERSITY OF GDANSK   (Poland)

^e AMERICAN HEART ASSOCIATION   (United States)

Author keywords

cardiovascular diseases; cost benefit analysis; diabetes mellitus; diet; food labeling; policy; prevention control

Indexed keywords

SUGAR;

ADULT; AGED; CARDIOVASCULAR DISEASE; CARDIOVASCULAR MORTALITY; COST CONTROL; COST EFFECTIVENESS ANALYSIS; DIET; DIETARY INTAKE; FEMALE; FOOD PACKAGING; HEALTH CARE COST; HEALTH STATUS; HUMAN; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; QUALITY ADJUSTED LIFE YEAR; REVIEW; SENSITIVITY ANALYSIS; SUGAR INTAKE; WILLINGNESS TO PAY; ADVERSE EVENT; CALORIC INTAKE; COMPUTER SIMULATION; CONSUMER ATTITUDE; COST BENEFIT ANALYSIS; DECISION MAKING; DIETARY REFERENCE INTAKE; ECONOMIC MODEL; ECONOMICS; FEEDING BEHAVIOR; FOOD AND DRUG ADMINISTRATION; LEGISLATION AND JURISPRUDENCE; MANAGEMENT; NUTRITIONAL STATUS; NUTRITIONAL VALUE; PROGRAM EVALUATION; UNITED STATES;

CARDIOVASCULAR DISEASES; CHOICE BEHAVIOR; COMPUTER SIMULATION; CONSUMER BEHAVIOR; COST SAVINGS; COST-BENEFIT ANALYSIS; DIET, HEALTHY; DIETARY SUGARS; ENERGY INTAKE; FEEDING BEHAVIOR; FOOD LABELING; HEALTH CARE COSTS; HUMANS; MODELS, ECONOMIC; NUTRITIONAL STATUS; NUTRITIVE VALUE; POLICY MAKING; PROGRAM EVALUATION; RECOMMENDED DIETARY ALLOWANCES; UNITED STATES; UNITED STATES FOOD AND DRUG ADMINISTRATION;

EID: 85067218897     PISSN: 00097322     EISSN: 15244539     Source Type: Journal    
DOI: 10.1161/CIRCULATIONAHA.118.036751     Document Type: Review

References (50)

1. Food and Drug Administration Food labeling: revision of the Nutrition and Supplement Facts Labels; final rule. 2016;21 CFR 101. Federal Register 2016 103 33742 33999
2. Te Morenga L, Mallard S, Mann J, Dietary sugars and body weight: systematic review and meta-Analyses of randomised controlled trials and cohort studies. BMJ 2013 346 e7492 e7492. doi: 10.1136/bmj.e7492
3. Malik VS, Pan A, Willett WC, Hu FB, Sugar-sweetened beverages and weight gain in children and adults: A systematic review and meta-Analysis. Am J Clin Nutr 2013 98 1084 1102. doi: 10.3945/ajcn.113.058362
4. Micha R, Peñalvo JL, Cudhea F, Imamura F, Rehm CD, Mozaffarian D, Association between dietary factors and mortality from heart disease, stroke, and type 2 diabetes in the United States. JAMA 2017 317 912 924. doi: 10.1001/jama.2017.0947
5. Malik VS, Popkin BM, Bray GA, Després JP, Willett WC, Hu FB, Sugar-sweetened beverages and risk of metabolic syndrome and type 2 diabetes: A meta-Analysis. Diabetes Care 2010 33 2477 2483. doi: 10.2337/dc10-1079
6. Yang Q, Zhang Z, Gregg EW, Flanders WD, Merritt R, Hu FB, Added sugar intake and cardiovascular diseases mortality among US adults. JAMA Intern Med 2014 174 516 524. doi: 10.1001/jamainternmed.2013.13563
7. Waters H, DeVol R, Weighing down America: The health and economic impact of obesity. Milken Institute 2016. https://www.milkeninstitute.org/publications/view/833. Accessed August 19, 2017
8. Powell ES, Smith-Taillie LP, Popkin BM, Added sugars intake across the distribution of US children and adult consumers: 1977-2012. J Acad Nutr Diet 2016 116 1543 1550. e1. doi: 10.1016/j.jand.2016.06.003
9. Office of Disease Prevention and Health Promotion 2015-2020 Dietary Guidelines for Americans. 2015. https://health.gov/dietaryguidelines/2015/. Accessed October 12, 2017
10. Drewnowski A, Rehm CD, Consumption of added sugars among US children and adults by food purchase location and food source. Am J Clin Nutr 2014 100 901 907. doi: 10.3945/ajcn.114.089458
11. Shangguan S, Afshin A, Shulkin M, Ma W, Marsden D, Smith J, Saheb-Kashaf M, Shi P, Micha R, Imamura F, Mozaffarian D, Food PRICE (Policy Review and Intervention Cost-Effectiveness) Project A meta-Analysis of food labeling effects on consumer diet behaviors and industry practices. Am J Prev Med 2019 56 300 314. doi: 10.1016/j.amepre.2018.09.024
12. Otite FO, Jacobson MF, Dahmubed A, Mozaffarian D, Trends in trans fatty acids reformulations of US supermarket and brand-name foods from 2007 through 2011. Prev Chronic Dis 2013 10 E85. doi: 10.5888/pcd10.120198
13. Poinski M, The future is now: Thousands of products already sport the revamped Nutrition Facts label. 2017. https://www.fooddive.com/news/the-future-is-now-Thousands-of-products-Already-sport-The-revamped-nutriti/507203/. Accessed November 8, 2017
14. Food & Drug Administration FDA proposes to extend compliance dates for Nutrition Facts Label final rules. 2017. https://www.fda.gov/food/newsevents/constituentupdates/ucm577264.htm. Accessed October 8, 2017
15. Pearson-Stuttard J, Bandosz P, Rehm CD, Penalvo J, Whitsel L, Gaziano T, Conrad Z, Wilde P, Micha R, Lloyd-Williams F, Capewell S, Mozaffarian D, O'Flaherty M, Reducing US cardiovascular disease burden and disparities through national and targeted dietary policies: A modelling study. PLoS Med 2017 14 e1002311. doi: 10.1371/journal.pmed.1002311
16. Pearson-Stuttard J, Bandosz P, Rehm CD, Afshin A, Peñalvo JL, Whitsel L, Danaei G, Micha R, Gaziano T, Lloyd-Williams F, Capewell S, Mozaffarian D, O'Flaherty M, Comparing effectiveness of mass media campaigns with price reductions targeting fruit and vegetable intake on US cardiovascular disease mortality and race disparities. Am J Clin Nutr 2017 106 199 206. doi: 10.3945/ajcn.116.143925
17. Centers for Disease Control and Prevention National Health and Nutrition Examination Survey [Internet]. https://www.cdc.gov/nchs/nhanes/index.htm. Accessed March 2, 2017
18. Rehm CD, Peñalvo JL, Afshin A, Mozaffarian D, Dietary intake among us adults, 1999-2012. JAMA 2016 315 2542 2553. doi: 10.1001/jama.2016.7491
19. Kypridemos C, Guzman-Castillo M, Hyseni L, Hickey GL, Bandosz P, Buchan I, Capewell S, O'Flaherty M, Estimated reductions in cardiovascular and gastric cancer disease burden through salt policies in England: An IMPACTNCD microsimulation study. BMJ Open 2017 7 e013791. doi: 10.1136/bmjopen-2016-013791
20. Alfons A, Kraft S, Templ M, Filzmoser P, Simulation of close-To-reality population data for household surveys with application to EU-SILC. Stat Methods Appl 2011 20 383 407. doi: 10.1007/s10260-011-0163-2
21. Food and Drug Administration Regulatory impact analysis for final rules on "Food labeling: revision of the nutrition and supplement facts label." 2016. https://www.fda.gov/downloads/AboutFDA/ReportsManualsForms/Reports/EconomicAnalyses/. Accessed April 17, 2017
22. Micha R, Shulkin ML, Peñalvo JL, Khatibzadeh S, Singh GM, Rao M, Fahimi S, Powles J, Mozaffarian D, Etiologic effects and optimal intakes of foods and nutrients for risk of cardiovascular diseases and diabetes: systematic reviews and meta-Analyses from the Nutrition and Chronic Diseases Expert Group (NutriCoDE). PLoS One 2017 12 e0175149. doi: 10.1371/journal.pone.0175149
23. Pearson-Stuttard J, Kypridemos C, Collins B, Mozaffarian D, Huang Y, Bandosz P, Capewell S, Whitsel L, Wilde P, O'Flaherty M, Micha R, Estimating the health and economic effects of the proposed US Food and Drug Administration voluntary sodium reformulation: microsimulation cost-effectiveness analysis. PLoS Med 2018 15 e1002551. doi: 10.1371/journal.pmed.1002551
24. Stringhini S, Carmeli C, Jokela M, Avendaño M, Muennig P, Guida F, Ricceri F, d'Errico A, Barros H, Bochud M, Chadeau-Hyam M, Clavel-Chapelon F, Costa G, Delpierre C, Fraga S, Goldberg M, Giles GG, Krogh V, Kelly-Irving M, Layte R, Lasserre AM, Marmot MG, Preisig M, Shipley MJ, Vollenweider P, Zins M, Kawachi I, Steptoe A, Mackenbach JP, Vineis P, Kivimäki M, LIFEPATH consortium Socioeconomic status and the 25 × 25 risk factors as determinants of premature mortality: A multicohort study and meta-Analysis of 1·7 million men and women. Lancet 2017 389 1229 1237. doi: 10.1016/S0140-6736(16)32380-7
25. Sullivan PW, Ghushchyan V, Preference-Based EQ-5D index scores for chronic conditions in the United States. Med Decis Making 2006 26 410 420. doi: 10.1177/0272989X06290495
26. Food and Drug Administration (FDA), Department of Health and Human Services (DHHS) Food and Drug Administration justification of estimates for appropriations committees. Fiscal year 2012 [Internet]. Food and Drug Administration (FDA). 2012. https://web.archive.org/web/20151229190025/ http://www.fda.gov/AboutFDA/ReportsManualsForms/Reports/BudgetReports/ucm242726.htm. Accessed July 10, 2017
27. American Heart Association Cardiovascular disease: A costly burden for America. Projections through 2035. https://healthmetrics.heart.org/wp-content/uploads/2017/10/Cardiovascular-Disease-A-Costly-Burden.pdf. Accessed Nov 4, 2017
28. Joo H, Dunet DO, Fang J, Wang G, Cost of informal caregiving associated with stroke among the elderly in the United States. Neurology 2014 83 1831 1837. doi: 10.1212/WNL.0000000000000986
29. Leal J, Luengo-Fernández R, Gray A, Petersen S, Rayner M, Economic burden of cardiovascular diseases in the enlarged European Union. Eur Heart J 2006 27 1610 1619. doi: 10.1093/eurheartj/ehi733
30. American Diabetes Association Economic costs of diabetes in the U.S. in 2012. Diabetes Care 2013 36 1033 1046. doi: 10.2337/dc12-2625
31. Dall TM, Yang W, Halder P, Pang B, Massoudi M, Wintfeld N, Semilla AP, Franz J, Hogan PF, The economic burden of elevated blood glucose levels in 2012: diagnosed and undiagnosed diabetes, gestational diabetes mellitus, and prediabetes. Diabetes Care 2014 37 3172 3179. doi: 10.2337/dc14-1036
32. Langa KM, Vijan S, Hayward RA, Chernew ME, Blaum CS, Kabeto MU, Weir DR, Katz SJ, Willis RJ, Fendrick AM, Informal caregiving for diabetes and diabetic complications among elderly Americans. J Gerontol B Psychol Sci Soc Sci 2002 57 S177 S186. doi: 10.1093/geronb/57.3.S177
33. Sanders GD, Neumann PJ, Basu A, Brock DW, Feeny D, Krahn M, Kuntz KM, Meltzer DO, Owens DK, Prosser LA, Salomon JA, Sculpher MJ, Trikalinos TA, Russell LB, Siegel JE, Ganiats TG, Recommendations for conduct, methodological practices, and reporting of cost-effectiveness analyses: second panel on cost-effectiveness in health and medicine. JAMA 2016 316 1093 1103. doi: 10.1001/jama.2016.12195
34. Anderson JL, Heidenreich PA, Barnett PG, Creager MA, Fonarow GC, Gibbons RJ, Halperin JL, Hlatky MA, Jacobs AK, Mark DB, Masoudi FA, Peterson ED, Shaw LJ, ACC/AHA statement on cost/value methodology in clinical practice guidelines and performance measures: A report of the American College of Cardiology/American Heart Association Task Force on Performance Measures and Task Force on Practice Guidelines. J Am Coll Cardiol 2014 63 2304 2322. doi: 10.1016/j.jacc.2014.03.016
35. Groot Koerkamp B, Stijnen T, Weinstein MC, Hunink MG, The combined analysis of uncertainty and patient heterogeneity in medical decision models. Med Decis Making 2011 31 650 661. doi: 10.1177/0272989X10381282
36. Mozaffarian D, Benjamin EJ, Go AS, Arnett DK, Blaha MJ, Cushman M, Das SR, de Ferranti S, Despres JP, Fullerton HJ, Howard VJ, Huffman MD, Isasi CR, Jimenez MC, Judd SE, Kissela BM, Lichtman JH, Lisabeth LD, Liu S, Mackey RH, Magid DJ, McGuire DK, Mohler ER 3rd, Moy CS, Muntner P, Mussolino ME, Nasir K, Neumar RW, Nichol G, Palaniappan L, Pandey DK, Reeves MJ, Rodriguez CJ, Rosamond W, Sorlie PD, Stein J, Towfighi A, Turan TN, Virani SS, Woo D, Yeh RW, Turner MB, Heart disease and stroke statistics-2016 update: A report from the American Heart Association. Circulation 2016 133 e38 360. doi: 10.1161/CIR.0000000000000350
37. Long MW, Gortmaker SL, Ward ZJ, Resch SC, Moodie ML, Sacks G, Swinburn BA, Carter RC, Claire Wang Y, Cost effectiveness of a sugar-sweetened beverage excise tax in the U.S. Am J Prev Med 2015 49 112 123. doi: 10.1016/j.amepre.2015.03.004
38. Pomeranz JL, Mozaffarian D, Micha R, Can the government require health warnings on sugar-sweetened beverage advertisements? JAMA 2018 319 227 228. doi: 10.1001/jama.2017.19209
39. Mozaffarian D, Liu J, Sy S, Huang Y, Rehm C, Lee Y, Wilde P, Abrahams-Gessel S, de Souza Veiga Jardim T, Gaziano T, Micha R, Cost-effectiveness of financial incentives and disincentives for improving food purchases and health through the US Supplemental Nutrition Assistance Program (SNAP): A microsimulation study. PLoS Med 2018 15 e1002661. doi: 10.1371/journal.pmed.1002661
40. Lee BY, Ferguson MC, Hertenstein DL, Adam A, Zenkov E, Wang PI, Wong MS, Gittelsohn J, Mui Y, Brown ST, Simulating the impact of sugar-sweetened beverage warning labels in three cities. Am J Prev Med 2018 54 197 204. doi: 10.1016/j.amepre.2017.11.003
41. Basu S, Seligman HK, Gardner C, Bhattacharya J, Ending SNAP subsidies for sugar-sweetened beverages could reduce obesity and type 2 diabetes. Health Aff (Millwood) 2014 33 1032 1039. doi: 10.1377/hlthaff.2013.1246
42. Wilde P, Huang Y, Sy S, Abrahams-Gessel S, Jardim TV, Paarlberg R, Mozaffarian D, Micha R, Gaziano T, Cost-effectiveness of a US national sugar-sweetened beverage tax with a multistakeholder approach: who pays and who benefits. Am J Public Health 2019 109 276 284. doi: 10.2105/AJPH.2018.304803
43. Wyness LA, Butriss JL, Stanner SA, Reducing the population's sodium intake: The UK Food Standards Agency's salt reduction programme. Public Health Nutr 2012 15 254 261. doi: 10.1017/S1368980011000966
44. Public Health England Sugar reduction, achieving the 20%. A technical report outlining progress to date, guidelines for industry, 2015 baseline levels in key foods and next steps. March 2017. https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment-data/file/604336/Sugar-reduction-achieving-the-20-.pdf. Accessed December 12, 2017
45. World Cancer Research Fund International Curbing global sugar consumption. Effective food policy actions to help promote healthy diets & tackle obesity. https://www.wcrf.org/sites/default/files/Curbing-Global-Sugar-Consumption.pdf. Accessed Nov 19, 2017
46. Global Food Research Program at University of North Carolina at Chapel Hill Chile [Internet]. http://globalfoodresearchprogram.web.unc.edu/multi-country-initiative/countries-where-we-work/chile/. Accessed January 19, 2018
47. Sacks G, Veerman JL, Moodie M, Swinburn B, 'Traffic-light' nutrition labelling and 'junk-food' tax: A modelled comparison of cost-effectiveness for obesity prevention. Int J Obes (Lond) 2011 35 1001 1009. doi: 10.1038/ijo.2010.228
48. Gortmaker SL, Wang YC, Long MW, Giles CM, Ward ZJ, Barrett JL, Kenney EL, Sonneville KR, Afzal AS, Resch SC, Cradock AL, Three interventions that reduce childhood obesity are projected to save more than they cost to implement. Health Aff (Millwood) 2015 34 1932 1939. doi: 10.1377/hlthaff.2015.0631
49. Park C, Wang G, Durthaler JM, Fang J, Cost-effectiveness analyses of antihypertensive medicines: A systematic review. Am J Prev Med 2017 53 6S2 S131 S142. doi: 10.1016/j.amepre.2017.06.020
50. Pandya A, Sy S, Cho S, Weinstein MC, Gaziano TA, Cost-effectiveness of 10-year risk thresholds for initiation of statin therapy for primary prevention of cardiovascular disease. JAMA 2015 314 142 150. doi: 10.1001/jama.2015.6822